US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAIL, Inc.

38.36

-1.1300-2.86%

Post-market: 38.30-0.0600-0.16%19:58 EDT

Volume:2.10M

Turnover:81.22M

Market Cap:1.38B

PE:-0.66

High:40.88

Open:40.24

Low:36.94

Close:39.49

Loading ...

Overview Company News Filings

Grail Inc. Conducted Annual Stockholders Meeting

Grail Inc. Announces New Equity Inducement Plan for Recently Hired Employees

New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report

Grail Inc. Announces New Compensation Agreement for Top Executives with Enhanced Severance Benefits

Stock Track | GRAIL Shares Plummet 5.03% as Investors Digest Q1 Revenue Miss

Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment

GRAIL Is Maintained at Buy by Canaccord Genuity

Stock Track | GRAIL Plummets 16.58% Pre-market on Q1 Revenue Miss, Overshadowing Positive Developments

Grail Shares Down 11.3% After Q1 Revenue Miss

THOMSON REUTERS

Investors Evaluate Impact of Inflation Report as US Futures Edge Higher Pre-Bell

MT Newswires Live

U.S. Stocks to Watch: Nvidia, AMD, UnitedHealth, American Eagle, Exelixis, Grail, and More

Stock Track | GRAIL Stock Plunges 16% Pre-market on Q1 Revenue Miss, Despite Narrower Loss

Stock Track | GRAIL Plunges 16% Pre-market on Q1 Revenue Miss Despite Narrower Loss

Shares of Grail Slip 17.6% Premarket After Q1 Revenue Miss

THOMSON REUTERS

Grail Inc : Canaccord Genuity Raises Target Price to $43 From $32

THOMSON REUTERS

Stock Track | GRAIL Plunges 18.40% After Hours on Q1 Revenue Miss, Despite Narrower Loss and Positive Trial Results

Grail Shares Fall As 1Q Revenue Misses Expectations

Grail Inc reports results for the quarter ended March 31 - Earnings Summary

Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":38.36,"timestamp":1749240000000,"preClose":39.49,"halted":0,"volume":2102823,"hourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.36,"latestTime":"19:58 EDT","volume":4157,"amount":159597.87,"timestamp":1749254286063},"delay":0,"floatShares":27396017,"shares":35973494,"eps":-58.51757,"marketStatus":"Market Closed","change":-1.13,"latestTime":"06-06 16:00:00 EDT","open":40.24,"high":40.88,"low":36.94,"amount":81217585.06776,"amplitude":0.099772,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-58.51757,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":39.49,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":39.49,"latestTime":"09:29 EDT","volume":971,"amount":38819.216716,"timestamp":1749216571005},"postHourTrading":{"tag":"盘后","latestPrice":38.3,"preClose":38.36,"latestTime":"19:58 EDT","volume":4157,"amount":159597.87,"timestamp":1749254286063},"volumeRatio":1.3952439101005851,"impliedVol":0.995,"impliedVolPercentile":0.6329},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":27396017,"roa":"-11.99%","roe":"-62.22%","lyrEps":-63.539968,"volumeRatio":1.3952439101005851,"shares":35973494,"dividePrice":0,"high":40.88,"amplitude":0.099772,"preClose":39.49,"low":36.94,"week52Low":12.33,"pbRate":"0.57","psRate":"10.56","week52High":63.99,"institutionHeld":0,"latestPrice":38.36,"eps":-58.51757,"divideRate":0,"volume":2102823,"delay":0,"ttmEps":-58.51757,"open":40.24,"prevYearClose":17.85,"prevWeekClose":38.41,"prevMonthClose":38.41,"prevQuarterClose":25.54,"fiveDayClose":38.41,"twentyDayClose":36.1,"sixtyDayClose":30.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539203881","title":"Grail Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2539203881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539203881?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:05","pubTimestamp":1748639157,"startTime":"0","endTime":"0","summary":"Grail Inc. held its Annual Meeting of Stockholders on May 29, 2025. At the meeting, stockholders elected William Chase as a Class I Director. Additionally, stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL8Pf9K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2539270182","title":"Grail Inc. Announces New Equity Inducement Plan for Recently Hired Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2539270182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539270182?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:05","pubTimestamp":1748635522,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, has announced the issuance of equity awards to 38 newly hired non-executive employees. These awards, in the form of restricted stock units  totaling 77,350 shares of GRAIL's common stock, serve as inducements for their acceptance of employment. The awards were granted under GRAIL's Inducement Equity Incentive Plan in alignment with Nasdaq Listing Rule 5635. The RSUs will vest over approximately four years, with 25% vesting on May 31, 2026, and subsequent vesting on each anniversary of this date, contingent on continued employment with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL60kcMB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2537327851","title":"New Tests Promise to Reveal the Secrets in Your Blood -- Journal Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2537327851","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537327851?lang=en_us&edition=fundamental","pubTime":"2025-05-23 22:00","pubTimestamp":1748008800,"startTime":"0","endTime":"0","summary":"Blood tests have long been an important tool for giving doctors a picture of a patient's health, from cholesterol levels to diabetes risk. Now new genetic science, AI analysis and other advances are providing even more sophisticated information from a simple vial of blood.A wave of cutting-edge diagnostic tests can now identify diseases such as cancer and Alzheimer's at much earlier stages, sometimes long before symptoms appear, as well as manage chronic disease and tailor treatments to individual patients. And new data derived from blood can help tailor treatments to individual patients.A number of the most sophisticated tests have already received approval or clearance from the Food and Drug Administration or are seeking it. Some new tests have been developed by labs that are certified to meet federal quality standards, so they can market the tests without FDA authorization. The agency is currently reviewing its policies to ensure such tests meet higher regulatory standards for accur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251131958.USD","BK4588","GH","BK4550","LU1059921491.USD","BK4196","BK4551","BK4585","LU0251142724.SGD","LU0742534661.SGD","GRAL","LH","BK4535","LU0048573561.USD","LU0006061336.USD","BK4139"],"gpt_icon":0},{"id":"2536406623","title":"Grail Inc. Announces New Compensation Agreement for Top Executives with Enhanced Severance Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2536406623","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536406623?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:06","pubTimestamp":1747425996,"startTime":"0","endTime":"0","summary":"Grail Inc. has announced new compensation terms for its top executives, as approved by the Compensation Committee of the Board of Directors. The amended offer letters for President Josh Ofman and Chief Financial Officer Aaron Freidin confirm their annual base salaries at $655,000 and $560,000, respectively, with the possibility of future increases. Both executives will continue to be eligible for a target bonus of 50% of their base salaries under the company's Variable Compensation Plan. The new terms also outline severance benefits, including a lump sum cash payment equal to 12 months of their annual base salary and target bonus, 12 months of healthcare coverage, and acceleration of any equity awards held. These provisions will apply if either executive is terminated without cause or resigns for good reason, subject to certain conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL5jnqPb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1108527984","title":"Stock Track | GRAIL Shares Plummet 5.03% as Investors Digest Q1 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1108527984","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108527984?lang=en_us&edition=fundamental","pubTime":"2025-05-16 23:54","pubTimestamp":1747410861,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company specializing in early cancer detection, saw its stock plummet 5.03% during Friday's intraday trading session. This decline appears to be a continued reaction to the company's disappointing first-quarter 2025 financial results released earlier in the week.The sustained sell-off follows GRAIL's after-hours plunge of 14.90% on Tuesday when the company reported its Q1 earnings. Despite posting a narrower-than-expected loss of $3.10 per share, beating analyst estima","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"1117497277","title":"Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1117497277","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117497277?lang=en_us&edition=fundamental","pubTime":"2025-05-16 14:43","pubTimestamp":1747377823,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, saw its stock plummet 14.90% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results. The sharp decline came despite the company reporting a narrower-than-expected loss, as revenue fell short of analyst expectations.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 million forecast by analys","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535045005","title":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535045005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535045005?lang=en_us&edition=fundamental","pubTime":"2025-05-15 01:55","pubTimestamp":1747245319,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera InvestmentEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL6N3RM0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","HOOD","NVDU","PVH","MAGN","NEM","ABBV","SNVD.UK","AUR","SEPN","SRE","BLUE","KKR","2NVD.UK","LOAR","MP","FRGE","MESA","3NVD.UK","CG","NVD2.UK","NFE","NVDS.UK","TXO","OKLO","RTX","HTZ","EXEL","NEXT","CIM","ANTA","GPI","MRP","AEO","NVIW.SI","NVDD","LEGN","JCI","NXT","NVD","SPRU","EWCZ"],"gpt_icon":1},{"id":"2535607218","title":"GRAIL Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2535607218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535607218?lang=en_us&edition=fundamental","pubTime":"2025-05-14 23:55","pubTimestamp":1747238100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2025 11:55 ET (15:55 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"1155418022","title":"Stock Track | GRAIL Plummets 16.58% Pre-market on Q1 Revenue Miss, Overshadowing Positive Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=1155418022","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155418022?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:50","pubTimestamp":1747230637,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.  saw its stock plummet 16.58% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results. The sharp decline came as the biotechnology company's revenue fell significantly short of analyst expectations, overshadowing other positive developments.Despite the revenue shortfall, GRAIL announced encouraging results from its NHS-Galleri trial, reporting positive top-line results from the prevalent screening round. The company also highlighted its st","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535274180","title":"Grail Shares Down 11.3% After Q1 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2535274180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535274180?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:31","pubTimestamp":1747229462,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM2S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2535202427","title":"Investors Evaluate Impact of Inflation Report as US Futures Edge Higher Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2535202427","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535202427?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:03","pubTimestamp":1747227790,"startTime":"0","endTime":"0","summary":"US equity futures posted narrow gains before Wednesday's opening bell as traders digested the impact of Tuesday's consumer inflation report.Dow Jones Industrial Average futures gained 0.1%, S&P 500 fu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UDOW","DJX","BK4129","USAW.SI","DXD","LUCY","USJW.SI","ECG","BK4139",".DJI","BK4198","PSQ","GRAL","BK7064","MYMmain","DDM","ISBC","QLD","NQmain","SQQQ","QID","DOG","TQQQ","ECG.AU",".SPX",".IXIC","BK4211","TSYW.SI","NVIW.SI","MNQmain","SDOW"],"gpt_icon":1},{"id":"2535523012","title":"U.S. Stocks to Watch: Nvidia, AMD, UnitedHealth, American Eagle, Exelixis, Grail, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2535523012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535523012?lang=en_us&edition=fundamental","pubTime":"2025-05-14 17:27","pubTimestamp":1747214842,"startTime":"0","endTime":"0","summary":"Stock futures were down slightly Wednesday after the S&P 500 moved into positive territory for the year as tech stocks powered higher.These stocks were poised to make moves Wednesday:Nvidia gained 1.9","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"07efdf5edf9d99771b022a9d9a139771","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNH","LU0267386448.USD","GRAL","LU2463028550.USD","IE00B42XCP33.USD","LU0823434583.USD","LU0444971666.USD","LU0276348264.USD","NVDA","LU2168563687.JPY","LU1506573853.SGD","EXEL","IE0003U64NQ7.SGD","LU0251132253.USD","LU2249611893.SGD","LU2290526834.HKD","IE00BN8TJ469.HKD","LU0127658192.USD","BK4515","IE00BFXG1179.USD","BK4512","AEO","LU1066053197.SGD","BK4501","LU2237438978.USD","LU0347712357.USD","BK4507","LU2250418816.HKD","IE00B3PB1722.GBP","LU0788109477.HKD","AMD","LU0823421416.USD"],"gpt_icon":0},{"id":"1127657427","title":"Stock Track | GRAIL Stock Plunges 16% Pre-market on Q1 Revenue Miss, Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1127657427","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127657427?lang=en_us&edition=fundamental","pubTime":"2025-05-14 16:14","pubTimestamp":1747210482,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.  saw its stock plummet 16.06% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results. The sharp decline came as the company's revenue fell short of analyst expectations, overshadowing a narrower-than-expected loss.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 million forecast by analysts. The company's net loss narrowed to $3.10 per share, be","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"1113688063","title":"Stock Track | GRAIL Plunges 16% Pre-market on Q1 Revenue Miss Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1113688063","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113688063?lang=en_us&edition=fundamental","pubTime":"2025-05-14 16:14","pubTimestamp":1747210464,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.  saw its stock plummet 16.06% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results. The sharp decline came as the company's revenue fell short of analyst expectations, overshadowing a narrower-than-expected loss and positive trial results.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 million forecast by analysts. The company's net loss narr","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535013539","title":"Shares of Grail Slip 17.6% Premarket After Q1 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2535013539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535013539?lang=en_us&edition=fundamental","pubTime":"2025-05-14 16:07","pubTimestamp":1747210060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2535986710","title":"Grail Inc : Canaccord Genuity Raises Target Price to $43 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2535986710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535986710?lang=en_us&edition=fundamental","pubTime":"2025-05-14 13:54","pubTimestamp":1747202090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM06B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1183553732","title":"Stock Track | GRAIL Plunges 18.40% After Hours on Q1 Revenue Miss, Despite Narrower Loss and Positive Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1183553732","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183553732?lang=en_us&edition=fundamental","pubTime":"2025-05-14 09:08","pubTimestamp":1747184927,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, saw its stock plummet 18.40% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results. The sharp decline came as the company's revenue fell short of analyst expectations, overshadowing a narrower-than-expected loss and positive trial results.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 m","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2535503566","title":"Grail Shares Fall As 1Q Revenue Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2535503566","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535503566?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:04","pubTimestamp":1747173840,"startTime":"0","endTime":"0","summary":"Shares of Grail fell after the biotechnology and healthcare company reported a narrower first-quarter loss, while revenue rose less than analysts expected.Shares slid 16% to $35.85 during Tuesday's after hours trading, though the stock is up more than 140% so far this year through the latest close.The Menlo Park, Calif.-based company narrowed its first quarter-loss to $106.2 million, or $3.10 a share, compared with a loss of $218.9 million, or $7.05 a share, a year earlier.Analysts polled by FactSet were expecting a loss of $3.99 per share.The net loss included $34.6 million of amortization of Illumina acquisition-related intangible items.Revenue rose to $31.8 million from $26.7 million during the year-ago quarter. Analysts were looking for sales of $35.2 million.Revenue from Galleri, the company's early-detection cancer tests, was up 24% year over year.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"2535080449","title":"Grail Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535080449","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535080449?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:02","pubTimestamp":1747170138,"startTime":"0","endTime":"0","summary":"Grail Inc reports results for the quarter ended March 31 - Earnings SummaryGrail Inc GRAL.OQ reported a quarterly adjusted loss of $3.09 per share for the quarter ended March 31, higher than the same ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL2XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"1115693753","title":"Stock Track | GRAIL Plunges 14.90% After-Hours on Q1 Revenue Miss Despite Narrower Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1115693753","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115693753?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:32","pubTimestamp":1747168354,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. , a healthcare company focused on early cancer detection, saw its stock plummet 14.90% in after-hours trading on Tuesday following the release of its first-quarter 2025 financial results. The sharp decline came despite the company reporting a narrower-than-expected loss, as revenue fell short of analyst expectations.For the quarter ended March 31, GRAIL reported revenue of $31.8 million, up from $26.7 million a year earlier but significantly below the $35.2 million forecast by analys","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"GRAL","fiscalQuarterEnding":"2025/03","expectedEps":-4.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.1},{"market":"US","date":"2025-02-20","symbol":"GRAL","fiscalQuarterEnding":"2024/12","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2024-11-12","symbol":"GRAL","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-3.94},{"market":"US","date":"2024-08-13","symbol":"GRAL","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-5.3},{"market":"US","date":"2024-06-25","symbol":"GRAL","reason":null,"defaultRemindTime":1719322200000,"announcedDate":"2024-06-05","type":"delisting","dateTimestamp":1719288000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2025-06-06","current":-0.742094,"percent":0.058559,"low":-0.873079,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"high":-0.135365,"avg":-0.370612,"sd":0.202668,"marketCap":1420593278},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278}],"updateTime":1749388973872}}}